Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells
Frédérique Souazé(Centre National de la Recherche Scientifique), Philippe Juin(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
BCL-XL directly modulates RAS signalling to favour cancer cell stemness
|Nature Communications|2017|46
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
|Cell Death and Disease|2022|20
Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts
|Scientific Reports|2024|15
Targeting of MCL-1 in breast cancer associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1